Subscribe to the Health News Watchdog podcast. Help get the word out by leaving a review and a rating.
As health care information flows from its source to the general public there are several opportunities for contamination. Who is doing this? And how?
The Alzheimer’s Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn’t been found. Is this irresponsible? Unethical? Potentially harmful?
Veteran emergency physicians Greg Henry, MD, and Jerome Hoffman, MD, discuss how misleading media messages feed health care myths that can lead to patient harms.
Do we have too much health care that’s supported by too little evidence? Ray Moynihan, PhD, thinks so. In this podcast, the erudite and personable Australian journalist-turned-researcher helps us make sense of the complex intersection of overdiagnosis, evidence-based medicine, and conflicts of interest.
The language of cancer has become part of our vernacular.
It not only reveals our values and beliefs, but also has considerable impact — ranging from the power to inform and inspire, to the potential to misinform and cause harm.
The doctor-patient relationship is a key determinant of the quality of our health care. But this relationship is changing quickly, and may actually be endangered. What does that mean for patients and providers? And what can we do about it?
Our microbiome. We’re told it may hold the key to better understanding and treating a host of diseases. But the supporting research isn’t even close to that point. Nonetheless, the media continues to hype the microbiome and that has consequences.
This podcast is about physicians who blog …
Why they do it, what they’ve taken away from the experience, and what they see as the role blogging plays in the medical information landscape.
Timothy Caulfield, the author of “Is Gwyneth Paltrow Wrong About Everything?” shares his thoughts on the battle of science vs. hype, public trust in science, the importance of social media in health care journalism, the art of communicating health care information, and — of course — the role of celebrity in pseudoscience.
In the past half year the FDA approved the first three gene therapies for use in the US.
This comes less than 18 years after the announcement that the human genome had been fully sequenced. It was a milestone wrapped in a promise; a promise that became known as “precision medicine.” But has that promise become reality?
In this podcast we turn to five leaders in their respective fields who’ve been intimately involved with this emerging technology. We ask them them to not only contrast what precision medicine is and may become, but also to help us clarify what holds promise and what’s just hype.
Tips & Resources for Analyzing Health Care Claims